Pediatrix Medical Group (NYSE:MD) Hits New 12-Month High – What’s Next?

Pediatrix Medical Group, Inc. (NYSE:MD) shares reached a new 52-week high during mid-day trading on Wednesday. The company traded as high as $31.62 and last traded at $31.5640, with a volume of 20,867 shares. The stock had previously closed at $30.60.

Analyst Upgrades and Downgrades

Several equities analysts have commented on MD shares. Weiss Ratings raised Pediatrix Medical Group from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, September 9th. UBS Group upped their target price on shares of Pediatrix Medical Group from $25.00 to $28.00 and gave the stock a “neutral” rating in a research report on Thursday, August 6th. Wall Street Zen raised shares of Pediatrix Medical Group from a “buy” rating to a “strong-buy” rating in a research report on Sunday, September 13th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $25.00 price target on shares of Pediatrix Medical Group in a research note on Wednesday, August 5th. Finally, Jefferies Financial Group cut shares of Pediatrix Medical Group from a “buy” rating to a “hold” rating and lifted their price target for the company from $27.00 to $28.00 in a research report on Wednesday, August 19th. One investment analyst has rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $27.20.

Pediatrix Medical Group Stock Up 5.7%

The company has a market cap of $2.53 billion, a P/E ratio of 17.58 and a beta of 0.62. The company’s 50-day moving average is $27.09 and its two-hundred day moving average is $23.95. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.28 and a quick ratio of 1.28.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings data on Thursday, October 29th. The company reported $0.72 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.65 by $0.07. Pediatrix Medical Group had a return on equity of 20.12% and a net margin of 7.66%. The business had revenue of $501.37 million for the quarter, compared to analysts’ expectations of $498.18 million. During the same period in the prior year, the firm posted $0.67 EPS. The firm’s quarterly revenue was up 1.7% on a year-over-year basis. As a group, equities analysts predict that Pediatrix Medical Group, Inc. will post 2.17 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the business. Choreo LLC boosted its position in shares of Pediatrix Medical Group by 5.7% during the third quarter. Choreo LLC now owns 8,361 shares of the company’s stock valued at $215,000 after buying an additional 448 shares during the last quarter. Keybank National Association OH boosted its position in shares of Pediatrix Medical Group by 2.0% during the first quarter. Keybank National Association OH now owns 22,941 shares of the company’s stock valued at $491,000 after buying an additional 458 shares during the last quarter. Nisa Investment Advisors LLC increased its holdings in Pediatrix Medical Group by 3.3% in the 3rd quarter. Nisa Investment Advisors LLC now owns 19,131 shares of the company’s stock worth $492,000 after buying an additional 605 shares in the last quarter. Hohimer Wealth Management LLC increased its holdings in Pediatrix Medical Group by 5.4% in the 3rd quarter. Hohimer Wealth Management LLC now owns 12,714 shares of the company’s stock worth $327,000 after buying an additional 655 shares in the last quarter. Finally, State of Wyoming increased its holdings in Pediatrix Medical Group by 4.5% in the 3rd quarter. State of Wyoming now owns 24,525 shares of the company’s stock worth $631,000 after buying an additional 1,060 shares in the last quarter. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc provides specialized physician-led healthcare services for women, infants and children. The company’s clinical offerings include neonatal and perinatal care, maternal-fetal medicine, pediatric medical subspecialties, pediatric hospitalist services and related services delivered in partnership with hospitals and healthcare systems.

Pediatrix-affiliated physicians and advanced practice providers generally work in hospital-based settings, including neonatal intensive care units, delivery rooms, pediatric units and outpatient practices.